A review on plant-derived natural products and their analogs with anti-tumor activity

Indian Journal of Pharmacology

Volumn 40, Issue 2, 2008, Pages 49-58

  Dholwani, K ^a   Saluja, A ^a   Gupta, A ^b   Shah, D ^b  

^a SARDAR PATEL UNIVERSITY   (India)

^b VEER NARMAD SOUTH GUJARAT UNIVERSITY   (India)

Author keywords

Anticancer activity; Antitumor compounds; Plant derived natural products

Indexed keywords

CHEBULINIC ACID; CUMINDYSOSIDE A; CUMINDYSOSIDE B; CUMINGIANOSIDE A; DITERPENE; DOCETAXEL; ETOPOSIDE; ETOPOSIDE DERIVATIVE; FUNCTIONAL GROUP; GI 331; INOTOPLICINE; IRINOTECAN; LIGNAN DERIVATIVE; MALLATUSINIC ACID; NATURAL PRODUCT; NAVELBINE; PACLITAXEL; PLANT EXTRACT; POLACANDRIN; PSEUDOLARIC ACID A; PSEUDOLARIC ACID B; PSEUDOLARIDE I; PUNICALAGIN; TENIPOSIDE; TOPOTECAN; TRICIN; TRITERPENE DERIVATIVE; UNINDEXED DRUG; VINBLASTINE SULFATE; VINCRISTINE SULFATE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CHINESE MEDICINE; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG ISOLATION; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; HERB; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHARMACOPHORE; REVIEW; TRADITIONAL MEDICINE; TUMOR XENOGRAFT;

EID: 44949219131     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.41038     Document Type: Review

References (59)

1. Lee KH. Human medicinal agents from plants. In: Kinghorn AD, Balandrin M, editors. ACS Symposium Series No. 534, Washington, DC: American Chemical Society; 1993. Chap.12.
2. Keller-Juslen C, Kuhn M, Von Wartburg A, Stahelin H. Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxin. J Med Chem 1971;14:936.
3. O'Dwyerm PJ, Alonso MT, Leyland-Jones B, Marsoni S. Teniposide: A review of 12 years of experience. Cancer Treat Rep 1984;68:1455.
4. Lee KH. Anticancer drug design based on plant-derived natural products. J Biomed Sci 1999;6:236.
5. Issell BF, Muggia FM, Carter SK, editors. Etoposide (VP-16) Current Status and New Developments. Orlando, FL: Academic Press; 1984.
6. Van Maanen JM, Retel J, deVries J, Pinedo HM. Mechanism of action of antitumor drug etoposide: A review. J Natl Cancer Inst 1988;80:1526-33.
7. Cragg G, Suffness M. Mechanism of action of antitumor drug etoposide: A review. Pharmacol Ther 1988;37:425.
8. Sinha BK, Myers CG. Metabolism of plant-derived anticancer agents. Biochem Pharmacol 1984;33:3725.
9. Haim N, Nemec J, Roman J, Sinha BK. Irreversible binding of etoposide (VP-16-213) to deoxyribonucleic acid and proteins. Biochem Pharmacol 1987;36:527.
10. Sakurai H, Miki T, Imakura Y, Shibuya M, Lee KH. In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins. Mol Pharmacol 1991;40:965.
11. Lee KH, Imakura Y, Haruna M, Beers SA, Thurston LS, Dal HJ, et al. Metal-and photo-induced cleavage of DNA by podophyllotoxin, etoposide and their related compounds. J Nat Prod 1989;52:606.
12. Wang ZW, Kuo YH, Schnur D, Bowen JP, Liu SY, Han FS, et al. Antitumor Agents 107 -New Cytotoxic 4-Alkylamino Analogues of 4′-Demethyl-Epipodophyllotoxin as Inhibitors of Human DNA Topoisomerase II. J Med Chem 1990;33:2660.
13. Huang S, Shih H, Su C, Yang WP. Antitumor agents 113-New 4 beta arylamino derivatives of 4′-O-demethylepipodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II. Cancer Lett 1996;77:110.
14. th AACR Annual Conference, Orlando, FL, May 19-22, 1993; Fossell FV, University of Texas MD Anderson Cancer Center and Chen J, Genelabs Technologies Inc, personal communications.
15. Zhou XM, Lee KJ, Cheng J, Wu SS, Chen HX, Guo X, et al. Antitumor agents 144 New gamma-lactone ring-modified arylamino etoposide analogs as inhibitors of human DNA topoisomerase II. J Med Chem 1994;37:287.
16. MacDonald TL, Lehnert EK, Loper JT, Chow KC, Ross WE. DNA topoisomerase in cancer. In: Potmesil M, Kohn KW, editors. New York: Oxford University Press; 1991. p. 119.
17. 2-GRS approach. J Med Chem 1996; 39:1383.
18. 2-GRS Approach. J Med Chem 1996;39:1396.
19. Ji Z, Wang HK, Bastow KF, Zhu XK, Cho SJ, Cheng YC, et al. Antitumor Agents 164 -Podophenazine, 2,3 -Dichloropodophenazine, Benzopodophenazine, and Their 4-β-p-Nitroaniline Derivatives as Novel DNA Topoisomerase II inhibitor. Bioorg Med Chem Lett 1997;7:607.
20. Bastow KF, Wang HK, Cheng YC, Lee KH. Antitumor agents 177-Design, synthesis and biological evaluation of novel etoposide analogs bearing pyrrolecarboxamidino group as DNA topoisomerase II inhibitors. Bioorg Med Chem 1997;5:1481.
21. Pan DJ, Li ZL, Hu CQ, Chen K, Chang JJ, Lee KH. Antitumor agents - CLXXIII. Synthesis and evaluation of camptothecin-4β-amino-4′-O- demethyl epipodo phyllotoxin conjugates as inhibitors of mammalian DNA topoisomerases and as cytotoxic agents. Planta Med 1990; 56:383.
22. Wu TS, Lin YM, Haruna M, Pan DJ, Shingu T, Chen YP, et al. The Cytotoxic Principles of Pseudolarix kaempferi: Pseudolaric Acid-A and -B and Related Derivatives. J Nat Prod 1991; 54:823.
23. Chen GF, Li ZL, Chen K, Tang CM, He X, Pan, DJ et al. Antitumor agents 119-kansuiphorins A and B, two novel antileukemic diterpene esters from euphorbia kansui. J Chem Soc Chem Commun 1990:1113.
24. Shi Q, Chen K, Fujioka T, Kashiwada Y, Chang JJ, Kozuka M, et al. Structure and stereochemistry of pseudolarolide E, a novel triterpene dilactone from Pseudolarix kaempferi. J Nat Prod 1992;55:1488.
25. Kashiwada Y, Fujioka T, Chang JJ, Chen IS, Mihashi M, Lee KH. Antitumor agents135-structure and stereochemistry of polacandrin, a new cytotoxic triterpene from polanisia dodecandra. J Org Chem 1992;57:6946.
26. Lee KH, Imakura Y, Sumida T, Wu RY, Hall IH, Huang HC. Anti-tumor agents 136-Cumingianosides A-F, potent antileukemic new triterpene glucosides, and cumindysosides A and B, trisnor-and tetranortriterpene glucosides with a 14,18cycloapoeuphane-type skeleton from Dysoxylum cumingianum. J Org Chem 1979;44:2180.
27. Kuo YH, Chen CH, Yang Kuo LM, King ML, Wu TS, Haruna M, et al. Antitumor agents 33 -Isolation and structural elucidation of bruceoside -A and B, novel antileukemic quassinoid glycosides, and brucein -D and -E from Brucea javanica. J Nat Prod 1990;53:422.
28. Kuo YH, Chen CH, Yang Kuo LM, King ML, Wu TS, Lu ST, et al. Antitumor agents 112 -emarginatine B, a novel potent cytotoxic sesquiterpene pyridine alkaloid from maytenus emarginata. Heterocycles 1989;29:1465.
29. Fujioka T, Kashiwada Y, Okabe H, Mihashi K, Lee KH. Antitumor agents 171. Cytotoxicities of lobatosides B, C, D and E, cyclic bisdesmosides isolated from Actinostemma lobatum maxim. Bioorg Med Chem Let 1996;6:2807-10.
30. Lee KH, Tagahara K, Suzuki H, Wu RY, Huang HC, Ito K, et al. Antitumor agents 171-Cytotoxicities of lobatosides B, C, D, and E, cyclic bisdesmosides isolated from Actinostemma lobatum maxim. J Nat Prod 1981;44:530.
31. Hayashi T, Smith FT, Lee KH. Antitumor agents 49 -Tricin, Kaempferol-3-0-β-D-Glucopyranoside and ( + )-nortrachelogenin, antileukemic principles from wikstroemia indica. J Med Chem 1987;30:2005.
32. Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA. Antitumor agents 89-Psychorubrin, a new cytotoxic naphthoquinone from Psychotria rubra and its structure-activity relationships. J Am Chem Soc 1966;88:3888.
33. Wani MC, Nicholas AW, Wall ME. Plant Antitumor Agents I: The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminate. J Med Chem 1986;29:2358.
34. Johnson PK, McCabe FL, Faucette LF, Hertzberg RP, Kingsbury WD, Boehm JC, et al. Plant antitumor agents 23: Synthesis and antileukemic activity of camptothecin analogs. Proc Am Assoc Cancer Res 1989;30:623.
35. Potmesil M, Pinedo H, editors. Camptothecins: New anticancer agents. Boca Raton, FL: CRC Press; 1995. p. 113.
36. Candiani I, Bedeschi A, Cabri W, Zarini F, Visentin G, Capolongo L, et al. Synthesis and cytotoxic activity of alkylidene-and alkyl-substituted camptothecins. Bioorg Med Chem Let 1997;7:847-50.
37. Kawato Y, Aonuma M, Hirota Y, Kuga H, Sato K. Intracellular roles of SN-38,a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 1991;51:4187.
38. Wang HK, Liu SY, Hwang KM, Taylor G, Lee KH. Synthesis of novel water-soluble 7-(aminoacylhydrazono)-formyl camptothecins with potent inhibition of DNA topoisomerase I. Bioorg Med Chem 1994;2:1397.
39. Kashiwada T, Nonaka G, Nishioka I, Lee KJ, Bori I, Fukushima Y, et al. Tannins as potent inhibitors of DNA topoisomerase II in vitro. J Pharm Sci 1993;82:487.
40. Kashiwada Y, Nonaka G, Nishioka I, Chang JJ, Lee KH. Antitumor agents 129. tannins and related compounds as selective cytotoxic agents. J Nat Prod 1992;55:1033.
41. Kashiwada Y, Bastow KF, Lee KH. Novel lignan derivatives as selective inhibitors of DNA topoisomerase II. Bioorg Med Chem Let 1995;5:905.
42. Chen CH, Yang LM, Lee TT, Shen YC, Zhang DC, Pan DJ, et al. Antitumor agents-CLI, Bis(helenalinyl)glutarate and bis(isoalantodiol-B) glutarate, potent inhibitors of human DNA topoisomerase II. Bioorg Med Chem 1994;2:137.
43. Lee KH, Ibuka T, Sims D, Muroaka O, Kiyokawa H, Hall IH, et al. Antitumor agents 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agents. J Med Chem 1981;24:924.
44. Lee KH, Imakura T, Sumida Y, Wu RY, Hall IH, Huang HC. Antitumor agents 33 Isolation and structural elucidation of bruceoside -A and -B, novel antileukemic quassinoid glycosides, and brucein -D and -E from Brucea javanica. J Org Chem 1979;44:2180.
45. Fukamiya N, Okano M, Miyamoto M, Tagahara K, Lee KH. Antitumor Agents 127. Bruceoside C, a New Cytotoxic Quassinoid Glucoside and Related Compounds from Brucea javanica. J Nat Prod 1992;55:468.
46. Omishi S, Fukamiya N, Okano M, Tagahara K, Lee KH. Bruceosides D, E, and F, three new cytotoxic quassinoid glucosides from brucea javanica. J Nat Prod 1995;58:1032.
47. Ohno N, Fukamiya N, Okano M, Tagahara K, Lee KH. Synthesis of cytotoxic ß uorinated quassinoids. Bioorg Med Chem 1997;5:1489.
48. Li L, Wang HK, Kuo SC, Lednicer D, Lin CM, Hamel E, et al. Antitumor agents 150. 2′,3′,4′,5′,5,6,7-substituted 2-Phenyl-4-quinolones and related compounds: Their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem 1994;37:1126.
49. Li L, Wang HK, Kuo SC, Wu TS, Mauger A, Lin CM, et al. Antitumor agents 155-synthesis and biological evaluation of 3′,6,7-substituted 2-Phenyl-4quinolones as antimicrotubule agents. J Med Chem 1994;37:3400.
50. Lee KH. Anticancer drug design based on plant-derived natural products. J Biomed Sci 1999;6:236-50.
51. Chen K, Kuo SC, Hsieh MC, Mauger A, Lin CM, Hamel E, et al. Antitumor agents 174 2′,3′,4′,5,6,7-substituted 2-Phenyl-1,8-naphthyridin-4-ones: Their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem 1997;40:2266.
52. Brossi A, editors. The Alkaloids. New York: Academic Press; 1984. Chapter 23.
53. Shi Q, Verdier-Pinard P, Brossi A, Hamel E, McPhail AT, Lee KH. Antitumor agents 172 -synthesis and biological evaluation of novel deacetamidothiocolchicin-7-ols and Ester analogs as antitubulin agents. J Med Chem 1997;40:961.
54. Shi Q, Chen K, Brossi A, Verdier-Pinard P, Hamel E, McPhail AT, et al. Antitumor Agents Part 184. Syntheses and antitubulin activity of compounds derived from reaction of thiocolchicone with amines: Lactams, alcohols, and ester analogs of allothiocolchicinoids. Helv Chim Acta 1998;81:1023.
55. Chang P, Lee KH, Shingu T, Hirayama T, Hall IH, Huang HC. Antitumor agents 50. morindaparvin-A, a new antileukemic anthraquinone, and alizarin-1-Methyl ether from morinda parvifolia, and the antileukemic activity of the related derivatives. J Nat Prod 1982;45:206.
56. Chang P, Lee KH. Cytotoxic antileukemic anthraquinones from Morinda parvifolia. Phytochemistry 1984;23:1733.
57. Chang P, Lee KH. Antitumor Agents 75. Synthesis of cytotoxic anthraquinones digiferruginol and morindaparvin-B. J Nat Prod 1985;48:948.
58. Rubin J, Kovack JS, Ames MM, Creagen ET, O'Connell MJ. Phase I study of two schedules of teroxirone. Cancer Treatment Rep 1987;71:489.
59. Johnson MG, Hiyokawa H, Tani S, Koyama J, Morris-Natschke SL, et al. Antitumor agents-CLXVII: Synthesis and structure-activity correlations of the cytotoxic anthraquinone 1,4-bis-(2,3-epoxypropylamino)-9,10- anthracenedione, and of related compounds. Bioorg Med Chem 1997;5:1469.